Biotechnology: Pharmaceutical Preparations

Management ChangeJul 15, 2026, 04:22 PM

Ensysce Biosciences COO Jeffrey Millard Resigns

AI Summary

Ensysce Biosciences, Inc. announced that Jeffrey Millard, the company's Chief Operating Officer, resigned from his position. The resignation was effective on July 10, 2026.

Key Highlights

Jeffrey Millard resigned as Chief Operating Officer of Ensysce Biosciences, effective July 10, 2026.

View SEC Filing

ENSC

Biotechnology: Pharmaceutical Preparations

Ensysce Biosciences, Inc.

Price Impact